Tuesday 16 April 2013

Testing lung cancer drugs and therapies in mice

National Cancer Institute (NCI) investigators have designed a genetically engineered mouse for use in the study of human lung squamous cell carcinoma (SCC). The results of this study, headed by Yinling Hu, Ph.D., an investigator in the Laboratory of Experimental Immunology, Center for Cancer Research, NCI, appeared in Cancer Cell. Read more here.

Study mentioned: Xiao Z, et al. The Pivotal Role of IKKα in the Development of Spontaneous Lung Squamous Cell Carcinomas. Cancer Cell. 2013; 23(4):527-540.

No comments:

Post a Comment